| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 18 companies in the Health Care REITs industry. Part of the Real Estate sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 29, 2022 | VTR Ventas, Inc. | Debra A Cafaro52 | Chairman and CEO | Sell | 69,602 | $63.40 | $4,412,975.61 | -8.3% | -18.4% | -29.0% | |
| Mar 10, 2022 | MPW Medical Properties Trust Inc | Michael G Stewart58 | Director | Sell | 6,000 | $20.26 | $121,560.00 | -2.7% | -18.1% | -57.4% | |
| Mar 4, 2022 | GMRE Global Medical Reit Inc. | Henry Cole | Director | Buy | 1,287 | $15.54 | $19,999.47 | +20.0% | - | - | |
| Mar 3, 2022 | GMRE Global Medical Reit Inc. | Jeffrey Busch | Chairman, President and CEO | Buy | 2,000 | $15.55 | $31,100.00 | +4.8% | - | - | |
| Mar 2, 2022 | VTR Ventas, Inc. | Debra A Cafaro52 | Chairman and CEO | Sell | 34,800 | $55.97 | $1,947,606.36 | -4.3% | +1.8% | -12.3% | |
| Dec 30, 2021 | NHI National Health Investors Inc | Robert G Adams59 | Director | Buy | 2,000 | $57.25 | $114,500.00 | +1.2% | +5.4% | -4.6% | |
| Dec 29, 2021 | SBRA Sabra Health Care Reit, Inc. | Harold W. Andrews Jr. | Executive VP, CFO & Secretary | Sell | 110,000 | $13.55 | $1,490,742.00 | -18.8% | +14.4% | +0.7% | |
| Dec 1, 2021 | NHI National Health Investors Inc | Robert T Webb64 | Director | Buy | 3,000 | $52.02 | $156,060.00 | +7.7% | +6.2% | +16.1% | |
| Nov 19, 2021 | DOC Healthpeak Properties, Inc. | Christine Garvey54 | Director | Sell | 300 | $34.36 | $10,306.50 | -1.3% | -6.0% | -24.8% | |
| Nov 16, 2021 | OHI Omega Healthcare Investors Inc | Gail D Makode | Chief Legal Officer | Buy | 1,000 | $28.73 | $28,730.00 | New | +1.0% | +13.8% | |
| Nov 15, 2021 | OHI Omega Healthcare Investors Inc | Kapila K Anand | Director | Buy | 1,000 | $28.32 | $28,317.60 | +7.3% | +2.2% | +19.8% | |
| Nov 12, 2021 | VTR Ventas, Inc. | Robert D. Reed | Director | Sell | 5,940 | $55.05 | $326,997.59 | -9.7% | -5.1% | -13.9% | |
| Nov 10, 2021 | VTR Ventas, Inc. | James D Shelton | Director | Sell | 5,940 | $54.20 | $321,945.03 | -9.1% | -7.1% | -15.0% | |
| Oct 1, 2021 | OHI Omega Healthcare Investors Inc | Neal Ballew | Chief Accounting Officer | Buy | 309 | $29.96 | $9,257.64 | +121.2% | -0.0% | +6.7% | |
| Sep 30, 2021 | NHI National Health Investors Inc | Robert T Webb64 | Director | Buy | 2,000 | $53.86 | $107,715.00 | +5.4% | +7.9% | +12.3% | |
| Sep 29, 2021 | NHI National Health Investors Inc | D. Eric Mendelsohn | CEO and President | Buy | 2,000 | $54.38 | $108,756.68 | +4.5% | +6.4% | +8.9% | |
| Sep 17, 2021 | NHI National Health Investors Inc | Robert T Webb64 | Director | Buy | 3,000 | $57.38 | $172,125.00 | +8.8% | -0.4% | +16.8% | |
| Sep 14, 2021 | NHI National Health Investors Inc | Robert T Webb64 | Director | Buy | 1,500 | $58.00 | $87,000.00 | +4.6% | -3.5% | +14.5% | |
| Sep 10, 2021 | NHI National Health Investors Inc | Robert T Webb64 | Director | Buy | 1,500 | $58.50 | $87,750.00 | +4.8% | -3.3% | +20.5% | |
| Sep 10, 2021 | UHT Universal Health Realty Income Trust | Michael Allan Domb | Director | Buy | 5,800 | $56.20 | $325,950.00 | +152.6% | +5.4% | -6.1% | |
| Sep 9, 2021 | DOC Healthpeak Properties, Inc. | Christine Garvey54 | Director | Sell | 575 | $36.20 | $20,813.28 | -2.4% | -2.2% | -20.1% | |
| Sep 9, 2021 | NHI National Health Investors Inc | Robert A McCabe Jr.58 | Director | Buy | 468 | $59.84 | $28,002.78 | +2.8% | -3.6% | +18.6% | |
| Sep 1, 2021 | OHI Omega Healthcare Investors Inc | Burke W Whitman50 | Director | Buy | 500 | $33.65 | $16,825.00 | +2.0% | -15.4% | +5.4% | |
| Sep 1, 2021 | VTR Ventas, Inc. | Debra A Cafaro52 | Chairman and CEO | Sell | 18,075 | $56.63 | $1,023,551.10 | -2.4% | -16.3% | -11.9% | |
| Aug 19, 2021 | GMRE Global Medical Reit Inc. | Jeffrey Busch | Chairman, President and CEO | Buy | 1,000 | $15.01 | $15,010.00 | +2.5% | - | - |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.